SCOPUS 정보 검색 플랫폼

Gut Pathogens

Volumn 2, Issue 1, 2010, Pages

Probiotic therapy - Recruiting old friends to fight new foes

(1) Sleator, Roy D a,b

a Munster Technological University (Ireland)

b UNIVERSITY COLLEGE CORK (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904599881 PISSN: None EISSN: 17574749 Source Type: Journal
DOI: 10.1186/1757-4749-2-5 Document Type: Review

Times cited : (17)

References (22)

1
- 77952556349
- The population genetics of antibiotic resistance: Integrating molecular mechanisms and treatment contexts
- 10.1038/nrg2778. 20479772
- The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. RC MacLean AR Hall GG Perron A Buckling, Nat Rev Genet 2010 11 405 414 10.1038/nrg2778 20479772
- (2010) Nat Rev Genet , vol.11 , pp. 405-414
- MacLean, R.C.¹ Hall, A.R.² Perron, G.G.³ Buckling, A.⁴

2
- 0043163537
- Alternatives to antibiotics: Bacteriocins, antimicrobial peptides and bacteriophages
- 12710486
- Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. RD Joerger, Poult Sci 2003 82 640 647 12710486
- (2003) Poult Sci , vol.82 , pp. 640-647
- Joerger, R.D.¹

3
- 51149087680
- Battle of the bugs
- 10.1126/science.321.5894.1294b. 18772416
- Battle of the bugs. RD Sleator C Hill, Science 2008 321 1294 1295 10.1126/science.321.5894.1294b 18772416
- (2008) Science , vol.321 , pp. 1294-1295
- Sleator, R.D.¹ Hill, C.²

4
- 68349126806
- Health-beneficial effects of probiotics: Its mode of action
- 10.1111/j.1740-0929.2009.00645.x. 20163595
- Health-beneficial effects of probiotics: Its mode of action. Y Ohashi K Ushida, Anim Sci J 2009 80 361 371 10.1111/j.1740-0929.2009.00645.x 20163595
- (2009) Anim Sci J , vol.80 , pp. 361-371
- Ohashi, Y.¹ Ushida, K.²

5
- 38349193433
- New frontiers in probiotic research
- 10.1111/j.1472-765X.2007.02293.x. 18028323
- New frontiers in probiotic research. RD Sleator C Hill, Lett Appl Microbiol 2008 46 143 147 10.1111/j.1472-765X.2007.02293.x 18028323
- (2008) Lett Appl Microbiol , vol.46 , pp. 143-147
- Sleator, R.D.¹ Hill, C.²

6
- 62749176490
- Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease
- 10.1017/S1466252308001540. 19102792
- Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease. TR Callaway TS Edrington RC Anderson RB Harvey KJ Genovese CN Kennedy DW Venn DJ Nisbet, Anim Health Res Rev 2008 9 217 225 10.1017/S1466252308001540 19102792
- (2008) Anim Health Res Rev , vol.9 , pp. 217-225
- Callaway, T.R.¹ Edrington, T.S.² Anderson, R.C.³ Harvey, R.B.⁴ Genovese, K.J.⁵ Kennedy, C.N.⁶ Venn, D.W.⁷ Nisbet, D.J.⁸

7
- 65249190283
- Lantibiotics: Diverse activities and unique modes of action
- 10.1016/j.jbiosc.2009.01.003. 19393544
- Lantibiotics: diverse activities and unique modes of action. SM Asaduzzaman K Sonomoto, J Biosci Bioeng 2009 107 475 487 10.1016/j.jbiosc.2009. 01.003 19393544
- (2009) J Biosci Bioeng , vol.107 , pp. 475-487
- Asaduzzaman, S.M.¹ Sonomoto, K.²

8
- 0035910508
- Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity
- 11038353
- Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. I Wiedemann E Breukink C van Kraaij OP Kuipers G Bierbaum B de Kruijff HG Sahl, J Biol Chem 2001 276 1772 1779 11038353
- (2001) J Biol Chem , vol.276 , pp. 1772-1779
- Wiedemann, I.¹ Breukink, E.² Van Kraaij, C.³ Kuipers, O.P.⁴ Bierbaum, G.⁵ De Kruijff, B.⁶ Sahl, H.G.⁷

9
- 62249177710
- Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics
- 10.1017/S1466252308001497. 18983725
- Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Y Sang F Blecha, Anim Health Res Rev 2008 9 227 235 10.1017/S1466252308001497 18983725
- (2008) Anim Health Res Rev , vol.9 , pp. 227-235
- Sang, Y.¹ Blecha, F.²

10
- 77956448098
- Probiotics and gastrointestinal disease: Successes, problems and future prospects
- 10.1186/1757-4749-1-19. 19930635
- Probiotics and gastrointestinal disease: successes, problems and future prospects. EP Culligan C Hill RD Sleator, Gut Pathog 2009 1 19 10.1186/1757-4749-1-19 19930635
- (2009) Gut Pathog , vol.1 , pp. 19
- Culligan, E.P.¹ Hill, C.² Sleator, R.D.³

11
- 69949129015
- The interaction between Listeria monocytogenes and the host gastrointestinal tract
- 10.1099/mic.0.030205-0. 19542009
- The interaction between Listeria monocytogenes and the host gastrointestinal tract. RD Sleator D Watson C Hill CG Gahan, Microbiology 2009 155 2463 2475 10.1099/mic.0.030205-0 19542009
- (2009) Microbiology , vol.155 , pp. 2463-2475
- Sleator, R.D.¹ Watson, D.² Hill, C.³ Gahan, C.G.⁴

12
- 0035154503
- Probiotics: Determinants of survival and growth in the gut
- 11157348
- Probiotics: determinants of survival and growth in the gut. A Bezkorovainy, Am J Clin Nutr 2001 73 399S 405S 11157348
- (2001) Am J Clin Nutr , vol.73
- Bezkorovainy, A.¹

13
- 33645648155
- Patho-biotechnology: Using bad bugs to do good things
- 16459072
- Patho-biotechnology: using bad bugs to do good things. RD Sleator C Hill, Curr Opin Biotechnol 2006 17 211 216 16459072
- (2006) Curr Opin Biotechnol , vol.17 , pp. 211-216
- Sleator, R.D.¹ Hill, C.²

14
- 36348934989
- 'Bioengineered Bugs' - A patho-biotechnology approach to probiotic research and applications
- 10.1016/j.mehy.2007.03.008. 17452084
- 'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications. RD Sleator C Hill, Med Hypotheses 2008 70 167 169 10.1016/j.mehy.2007.03.008 17452084
- (2008) Med Hypotheses , vol.70 , pp. 167-169
- Sleator, R.D.¹ Hill, C.²

15
- 70349237033
- Rational design of improved pharmabiotics
- Rational design of improved pharmabiotics. RD Sleator C Hill, J Biomed Biotechnol 2009 2009 87 2752
- (2009) J Biomed Biotechnol , vol.2009 , pp. 87-2752
- Sleator, R.D.¹ Hill, C.²

16
- 35448994743
- Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003
- 10.1099/mic.0.2007/006510-0. 17906153
- Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. VM Sheehan RD Sleator C Hill GF Fitzgerald, Microbiology 2007 153 3563 3571 10.1099/mic.0.2007/006510-0 17906153
- (2007) Microbiology , vol.153 , pp. 3563-3571
- Sheehan, V.M.¹ Sleator, R.D.² Hill, C.³ Fitzgerald, G.F.⁴

17
- 56049113712
- Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract
- 10.1186/1471-2180-8-176. 18844989
- Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract. D Watson RD Sleator C Hill CG Gahan, BMC Microbiol 2008 8 176 10.1186/1471-2180-8-176 18844989
- (2008) BMC Microbiol , vol.8 , pp. 176
- Watson, D.¹ Sleator, R.D.² Hill, C.³ Gahan, C.G.⁴

18
- 45249108415
- Designer probiotics: A potential therapeutic for Clostridium difficile?
- 10.1099/jmm.0.47697-0. 18480340
- Designer probiotics: a potential therapeutic for Clostridium difficile? RD Sleator C Hill, J Med Microbiol 2008 57 793 794 10.1099/jmm.0.47697-0 18480340
- (2008) J Med Microbiol , vol.57 , pp. 793-794
- Sleator, R.D.¹ Hill, C.²

19
- 33745631768
- From cheese to pharma: A designer probiotic for IBD
- 10.1016/j.cgh.2006.05.034. 16829347
- From cheese to pharma: a designer probiotic for IBD. CO Elson, Clin Gastroenterol Hepatol 2006 4 836 837 10.1016/j.cgh.2006.05.034 16829347
- (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 836-837
- Elson, C.O.¹

20
- 77953250931
- Receptor-mimic probiotics: Potential therapeutics for bacterial toxin-mediated enteric diseases
- 10.1586/egh.10.30. 20528111
- Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseases. AW Paton R Morona JC Paton, Expert Rev Gastroenterol Hepatol 2010 4 253 255 10.1586/egh.10.30 20528111
- (2010) Expert Rev Gastroenterol Hepatol , vol.4 , pp. 253-255
- Paton, A.W.¹ Morona, R.² Paton, J.C.³

21
- 33845408482
- Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14
- 10.1111/j.1462-5822.2006.00772.x. 16879452
- Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. JJ Liu G Reid Y Jiang MS Turner CC Tsai, Cell Microbiol 2007 9 120 130 10.1111/j.1462-5822.2006.00772. x 16879452
- (2007) Cell Microbiol , vol.9 , pp. 120-130
- Liu, J.J.¹ Reid, G.² Jiang, Y.³ Turner, M.S.⁴ Tsai, C.C.⁵

22
- 77949360853
- Probiotics: Multifarious oral vaccine against infectious traumas
- 20100178
- Probiotics: multifarious oral vaccine against infectious traumas. S Amdekar D Dwivedi P Roy S Kushwah V Singh, FEMS Immunol Med Microbiol 2010 58 299 306 20100178
- (2010) FEMS Immunol Med Microbiol , vol.58 , pp. 299-306
- Amdekar, S.¹ Dwivedi, D.² Roy, P.³ Kushwah, S.⁴ Singh, V.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.